0000891293-15-000032.txt : 20150904 0000891293-15-000032.hdr.sgml : 20150904 20150904185430 ACCESSION NUMBER: 0000891293-15-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150904 FILED AS OF DATE: 20150904 DATE AS OF CHANGE: 20150904 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plunkett Matthew CENTRAL INDEX KEY: 0001557551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151095253 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE, SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-09-04 0 0000891293 CTI BIOPHARMA CORP ctic 0001557551 Plunkett Matthew 3101 WESTERN AVENUE, SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Corporate Development Common Stock 2015-09-04 4 F 0 12526 1.52 D 659214 D Common Stock 2015-09-04 4 S 0 5500 1.53 D 653714 D Common Stock 2015-09-04 4 S 0 1700 1.535 D 652014 D Common Stock 2015-09-04 4 S 0 1000 1.54 D 651014 D common Stock 2015-09-04 4 S 0 1800 1.55 D 649214 D Represents shares withheld by CTIC to satisfy minimum tax withholding obligations on the vesting of restricted stock. The sale was effected pursuant to a Rule 10b5-1 trading plans. By: Louis A. Bianco, Attorney-in-fact For: Matthew Plunkett 2015-09-04